The Future Medicines Institute (FMI) requires a Surface Plasmon Resonance (SPR) system with advanced capabilities for real-time, label-free analysis of biomolecular interactions.
(Maximum budget available for Equipment inclusive of 3 years extended warranty & annual preventative maintenance is is £330,000).
The primary objective of procuring an SPR device is to enhance FMI’s capacity to characterise binding kinetics, affinity, and specificity of biomolecular interactions, thereby strengthening its protein science and drug discovery…

You must be logged in to view the rest of this content, click here to login

Don't have an account, click to sign up for our 14-day free trial.